Heart failure is a severe health problem that is characterized by an increasing prevalence and economic cost. According to the American Heart Association, in the United States nearly one million new cases are reported each year. NT-proBNP is established diagnostic and prognostic biomarker of heart failure.

We provide a broad range of well characterized monoclonal antibodies that allow for the development of sensitive and reliable immunoassays that are suitable for the detection of proBNP, NT-proBNP and BNP in clinical samples. We also provide different recombinant antigens that can be used as standards and calibrators in immunoassays. You will now have the opportunity to learn more about NT-proBNP by watching the following video:

• Cat# 4BNP2cc: BNP, human, antibody, in vitro
  
• Cat# 4NT1cc: NT-proBNP, human, antibody, in vitro
• Cat# 4NT1: NT-proBNP, human, antibody
• Cat# 4BFab5cc: Immune complex 24C5-BNP proBNP, antibody, in vitro
• Cat# 4BFab5: Immune complex 24C5-BNP_proBNP, antibody
• Cat# 8NT2: NT-proBNP, recombinant, human
• Cat# 8PRO9: proBNP, recombinant, human
• Cat# 8GBP3: Recombinant human proBNP, glycosylated
  
• Cat# 8BFP: BNP and NT-proBNP Free Plasma